Skip to main
JNJ

JNJ Stock Forecast & Price Target

JNJ Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 32%
Buy 32%
Hold 37%
Sell 0%
Strong Sell 0%

Bulls say

Johnson & Johnson is a diversified healthcare company with a strong portfolio in both pharmaceuticals and MedTech. The company has a solid pipeline and is focused on M&A, while also maintaining a commitment to diversity and sustainability. Potential risks include disappointing product launches and concerns about drug pricing and tariffs, but overall, JNJ is expected to see growth and increased EPS and FCF in the coming years.

Bears say

Johnson & Johnson is a well-diversified healthcare company with a strong focus on innovation. However, the potential impact of drug patent expirations and the risks associated with its MedTech division could hinder future revenue growth. Additionally, the company may face challenges related to drug pricing and ongoing litigation. Its strong M&A focus may also bring along potential risks.

JNJ has been analyzed by 19 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 32% recommend Buy, 37% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Johnson & Johnson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Johnson & Johnson (JNJ) Forecast

Analysts have given JNJ a Buy based on their latest research and market trends.

According to 19 analysts, JNJ has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $267.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $267.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Johnson & Johnson (JNJ)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.